South Korea FDA Says Quarter Of Generics Kept Off Market In 2008
This article was originally published in PharmAsia News
Executive Summary
South Korea's FDA says about one-quarter of generic drugs headed for the market were blocked in 2008 because they were not bioequivalent to the branded version